SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001072613-15-000235
Filing Date
2015-03-24
Accepted
2015-03-24 15:43:57
Documents
1
Group Members
C. RICHARD KRAMLICHCHARLES W. NEWHALL IIIFOREST BASKETTKRISHNA KOLLURIMARK W. PERRYMICHAEL JAMES BARRETTNEA 11 GP LLCNEA PARTNERS 11 LIMITED PARTNERSHIPNEA PARTNERS 9 LIMITED PARTNERSHIPNEW ENTERPRISE ASSOCIATES 11 LIMITED PARTNERSHIPPETER J. BARRISRYAN D

Document Format Files

Seq Description Document Type Size
1 AMICUS THERAPEUTICS amicus-sch13d_17787.htm SC 13D/A 139295
  Complete submission text file 0001072613-15-000235.txt   141255
Mailing Address
Business Address 1119 ST PAUL STREET BALTIMORE MD 21202 4102440115
NEW ENTERPRISE ASSOCIATES 9 L P (Filed by) CIK: 0001102947 (see all company filings)

IRS No.: 522189689 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512 (609) 662-2000
AMICUS THERAPEUTICS INC (Subject) CIK: 0001178879 (see all company filings)

IRS No.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-83043 | Film No.: 15721629
SIC: 2834 Pharmaceutical Preparations